DJIA 17,893.63 -82.68 -0.46%
NASDAQ 4,927.77 -19.67 -0.40%
S&P 500 2,079.02 -7.22 -0.35%
market minute promo

Exelixis (NASDAQ: EXEL)

2.58 -0.12 (-4.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EXEL $2.58 -4.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.72
Previous Close $2.70
Daily Range $2.62 - $2.72
52-Week Range $1.26 - $4.55
Market Cap $505.4M
P/E Ratio -1.96
Dividend (Yield) $0.00 (0.0%)
Volume 780,209
Average Daily Volume 4,255,080
Current FY EPS -$0.88

Sector

Healthcare

Industry

Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website: http://www.exelixis.com/

News & Commentary

Why Exelixis, Inc. Shares Skyrocketed 57% in February

Exelixis shares soared in February as shareholders await two key catalysts.

Is Exelixis (EXEL) Stock a Solid Choice Right Now? - Tale of the Tape

Exelixis (EXEL) Highlighted As Weak On High Volume

18 Biotech Stocks These Wall Street Analysts Are Tracking

Exelixis (EXEL) In A Perilous Reversal

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

XBI, FMI, EXEL, HALO: Large Inflows Detected at ETF

Looking Ahead at Exelixis, Inc.

The biotech faces two major value-creating events in 2015.

Exelixis' (EXEL) CEO Mike Morrissey on Q4 2014 Results - Earnings Call Transcript

Exelixis (EXEL) Q4 2014 Results - Earnings Call Webcast

See More EXEL News...

EXEL's Top Competitors

EXEL $2.58 (-4.44%)
Current stock: EXEL
TMO $135.75 (0.13%)
Current stock: TMO
ILMN $185.55 (-1.10%)
Current stock: ILMN
WAT $125.09 (0.12%)
Current stock: WAT